CWG
AEGR

C WorldWide Group’s Aegerion Pharmaceuticals AEGR Stock Holding History

C WorldWide Group’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-55,940
Closed -$1.46M – 143
2015
Q1 		$1.46M Hold
55,940
– – 0.02% 93
2014
Q4 		$1.17M Buy
55,940
+10,940
+24% +$276K 0.02% 84
2014
Q3 		$1.51M Buy
+45,000
New +$1.4M 0.02% 84

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

C WorldWide Group's AEGR Position: Q2 2015 in Review

C WorldWide Group sold out of Aegerion Pharmaceuticals (AEGR) in Q2 2015, closing a stake of 55,940 shares — an estimated $1.46M sold.

C WorldWide Group first reported a position in AEGR in Q3 2014 and held it in 3 quarters. The position peaked at $1.51M in Q3 2014. 97 funds tracked by Wall St. Rank hold AEGR as of Q2 2015.

  • C WorldWide Group reported no remaining Aegerion Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • C WorldWide Group sold 55,940 Aegerion Pharmaceuticals shares in Q2 2015, an estimated $1.46M.
  • C WorldWide Group first reported a position in Aegerion Pharmaceuticals in Q3 2014 and held it in 3 quarters.
  • C WorldWide Group's Aegerion Pharmaceuticals position peaked at $1.51M in Q3 2014.
  • 97 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2015.

Based on C WorldWide Group's 13F filing for Q2 2015, filed 21 Jul 2015.